RecQ-like helicase 4 (RECQL4) exacerbates resistance to oxaliplatin in colon adenocarcinoma via activation of the PI3K/AKT signaling pathway

Oxaliplatin (OXA) resistance is a great challenge for colon adenocarcinoma (COAD) chemotherapy. The promoting role of RecQ-Like Helicase 4 (RECQL4) in chemoresistance to platinum-based drugs has been identified, whereas the effect and specific mechanism of RECQL4 in regulating OXA resistance within...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Fei, Wang, Leiming, Jin, Kangpeng, Wu, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806715/
https://www.ncbi.nlm.nih.gov/pubmed/34477047
http://dx.doi.org/10.1080/21655979.2021.1964156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806715/
https://www.ncbi.nlm.nih.gov/pubmed/34477047
http://dx.doi.org/10.1080/21655979.2021.1964156

Ejemplares similares